Drug Shortage Report for VIOKACE
Report ID | 173999 |
Drug Identification Number | 02241933 |
Brand name | VIOKACE |
Common or Proper name | pancrelipase |
Company Name | NESTLE ENTERPRISES S.A. |
Market Status | MARKETED |
Active Ingredient(s) | AMYLASE PROTEASE LIPASE |
Strength(s) | 113400UNIT 112500UNIT 20880UNIT |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 tablet bottles |
ATC code | A09AA |
ATC description | DIGESTIVES, INCL ENZYMES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-11-08 |
Actual start date | 2022-11-08 |
Estimated end date | Unknown |
Actual end date | 2022-12-22 |
Shortage status | Resolved |
Updated date | 2022-12-23 |
Company comments | Drug product is being released today. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 12, RUE ENTRE-DEUX-VILLES VEVEY, -- SWITZERLAND 1800 |
Company contact information | kfeltmate@apcipharma.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-12-23 | English | Compare |
v7 | 2022-12-22 | French | Compare |
v6 | 2022-12-22 | English | Compare |
v5 | 2022-12-22 | French | Compare |
v4 | 2022-12-22 | English | Compare |
v3 | 2022-11-09 | English | Compare |
v2 | 2022-11-08 | French | Compare |
v1 | 2022-11-08 | English | Compare |
Showing 1 to 8 of 8